InSphero Expands 3D Microtissue Portfolio Through Strategic Agreement with Tessara Therapeutics
News 06.06.2025 InSphero, the global leader in scalable and reliable 3D in vitro cell culture solutions for drug discovery, has entered into a distribution agreement with Tessara Therapeutics, an Australian biotech company known for its advanced neuronal microtissue technology. This agreement further strengthens our portfolio of physiologically relevant 3D models and enables us to offer best-in-class neuronal...